Rosandra N. Kaplan
#40,390
Most Influential Person Now
American pediatric oncologist and scientist
Rosandra N. Kaplan's AcademicInfluence.com Rankings
Rosandra N. Kaplanphilosophy Degrees
Philosophy
#12212
World Rank
#16927
Historical Rank
#2377
USA Rank
Logic
#9037
World Rank
#11398
Historical Rank
#1557
USA Rank
Download Badge
Philosophy
Rosandra N. Kaplan's Degrees
- Doctorate Medicine Harvard University
Why Is Rosandra N. Kaplan Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.
Rosandra N. Kaplan's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET (2012) (3042)
- VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche (2005) (2975)
- 4-1BB Costimulation Ameliorates T Cell Exhaustion Induced by Tonic Signaling of Chimeric Antigen Receptors (2015) (1098)
- Pre-metastatic niches: organ-specific homes for metastases (2017) (1084)
- Preparing the "soil": the premetastatic niche. (2006) (635)
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy (2014) (543)
- Migratory neighbors and distant invaders: tumor-associated niche cells. (2008) (393)
- The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. (2013) (361)
- Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond (2007) (332)
- Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma. (2018) (243)
- Niche-to-niche migration of bone-marrow-derived cells. (2007) (222)
- KLF4-dependent perivascular cell plasticity mediates pre-metastatic niche formation and metastasis (2017) (137)
- Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. (2013) (136)
- Priming the 'soil' for breast cancer metastasis: the pre-metastatic niche. (2006) (135)
- Toward a Drug Development Path That Targets Metastatic Progression in Osteosarcoma (2014) (123)
- Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche. (2016) (103)
- Neoangiogenesis contributes to the development of hemophilic synovitis. (2011) (97)
- MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research (2016) (77)
- Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation (2015) (75)
- Genetically engineered myeloid cells rebalance the core immune suppression program in metastasis (2021) (64)
- New fusion sarcomas: histopathology and clinical significance of selected entities. (2019) (55)
- Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells (2017) (51)
- Corrigendum: Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET (2016) (39)
- Id1 Represses Osteoclast-Dependent Transcription and Affects Bone Formation and Hematopoiesis (2009) (32)
- Innate immune cells in the tumor microenvironment. (2021) (24)
- Anaplastic lymphoma kinase (ALK) Gene Rearrangement in Children and Young Adults with Mesothelioma. (2019) (20)
- Physiological, Tumor, and Metastatic Niches: Opportunities and Challenges for Targeting the Tumor Microenvironment. (2015) (15)
- The functional interplay between systemic cancer and the hematopoietic stem cell niche. (2016) (13)
- Infectious Complications of CAR T-Cell Therapy Across Novel Antigen Targets in the first 30 days. (2021) (13)
- CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice (2021) (12)
- The IL-6 / JAK / Stat 3 Feed-Forward Loop Drives Tumorigenesis and Metastasis 1 , 2 (2013) (11)
- Pediatric PK/PD Phase I Trial of Pexidartinib in Relapsed and Refractory Leukemias and Solid Tumors Including Neurofibromatosis Type I–Related Plexiform Neurofibromas (2020) (9)
- Phase 1 trial of lyso-thermosensitive liposomal doxorubicin (LTLD) and magnetic resonance guided high intensity focused ultrasound (MR-HIFU) for pediatric refractory solid tumors. (2017) (8)
- ENABLE (Exportable Notation and Bookmark List Engine): an Interface to Manage Tumor Measurement Data from PACS to Cancer Databases (2017) (7)
- Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas (2021) (7)
- Phase I study of pexidartinib (PLX3397) in children with refractory leukemias and solid tumors including neurofibromatosis type I (NF1) related plexiform neurofibromas (PN). (2017) (6)
- The Immunotherapy Landscape in Adrenocortical Cancer (2021) (6)
- Infectious Complications Associated with CAR T-Cell Therapy (2019) (5)
- Mapping the switch that drives the pre-metastatic niche (2020) (3)
- Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma (2022) (3)
- Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma. (2021) (2)
- Kaplan et al. reply (2009) (2)
- Targeting tumor microenvironment and metastasis in children with solid tumors (2021) (2)
- Abstract 4126: CSF-1R inhibition blocks rhabdomyoscarcoma metastasis by polarizing macrophage differentiation (2015) (2)
- Abstract 3914: KLF4-dependent perivascular plasticity enhances pre-metastatic niche formation and metastasis (2017) (1)
- Bone marrow-derived progenitor cells develop into myeloid-derived suppressor cells at metastatic sites (2013) (1)
- Report of Canonical BCR-ABL1 Fusion in Glioblastoma. (2021) (1)
- Pediatric adrenocortical carcinoma (2022) (1)
- Abstract LB-284: Bone marrow-derived progenitor cells develop into myeloid-derived suppressor cells at metastatic sites. (2013) (1)
- Abstract B007: Remodeling the hyaluronan-rich tumor extracellular matrix using hyaluronidase-expressing genetically engineered MSCs for tumor regression and metastasis prevention in sarcomas (2023) (0)
- 307 IL12 genetically engineered myeloid cells effectively target the myeloid-enriched tumor and metastatic microenvironment in an immune-competent murine model of osteosarcoma (2022) (0)
- Abstract B017: Characterizing the key stromal and immune players in the microenvironment of primary and metastatic chordoma (2023) (0)
- Abstract 760: Identifying candidate genes that regulate tumor cell dormancy (2016) (0)
- Abstract 4585: Breaking metastatic dormancy during surgical resection of a primary tumor and implications for treatment strategies. (2013) (0)
- Interactions Between Megakaryocytes and Tumour Cells at the Bone Marrow Vascular Stem Cell Niche Promote Tumour Growth and Metastasis. (2009) (0)
- Abstract 2074: Metastasis prevention using fibroblast activation protein-targeting prodrugs at the pre-metastatic niche (2014) (0)
- Cancer Metastasis: Exploring the Earliest Steps in Metastasis: The Pre-metastatic Niche (2011) (0)
- Abstract A46: Charting the synthetic lethality landscape in pediatric cancer to advance whole-exome precision-based treatments (2020) (0)
- EPEN-26. Chemokine receptor blockade reverses CCL2 mediated immunosuppression and restores CAR-T cell function in posterior fossa ependymoma (2022) (0)
- Transcriptomic and epigenetic profiling of tumor-associated monocyte function (2022) (0)
- 362 Defining T cell exhaustion and memory correlates of GD2 CAR T cell expansion in pediatric patients with solid tumor malignancies (2022) (0)
- Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials. (2022) (0)
- 1066 POSTER lnterleukin-6 Increases Metastasis Formation Through Mobilization of Immature Myeloid Cells to the Pre-metastatic Niche (2011) (0)
- Abstract 5139: Adjuvant immunotherapy targeting CSF1R to limit metastatic progression (2016) (0)
- Abstract 5211: Dual E-selectin and CXCR4 inhibition reduces tumor growth and metastatic progression in an orthotopic model of osteosarcoma (2018) (0)
- Id1 negatively regulates osteoclast differentiation and maintains hematopoietic stem cell niche homeostasis (2008) (0)
- Genetically Engineered Myeloid Cells Rebalance the Core Regulatory Immune Suppression Program in Metastasis (2021) (0)
- Patient-Derived Organoids and Their Potential for Precision Medicine in Neuroendocrine Tumors (2023) (0)
- Megakaryocytes and the vascular niche in bone marrow metastasis (2009) (0)
- Safety and feasibility of magnetic resonance-guided high intensity focused ultrasound (MR-HIFU) for the ablation of relapsed or refractory pediatric solid tumors. (2016) (0)
- Abstract CT142: GD2.Ox40.CD28.z CAR T cell trial in neuroblastoma and osteosarcoma (2022) (0)
- 996 Functional and transcriptomic profiling of myeloid cells in pediatric solid tumors to inform next generation immunotherapy (2022) (0)
- Role of Mesenchymal-Derived Stem Cells in Stimulating Dormant Tumor Cells to Proliferate and Form Clinical Metastases (2016) (0)
- Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells (2017) (0)
- Abstract 3058: Bone marrow hematopoietic stem cell niche activation and mobilization fosters the metastatic niche (2014) (0)
- Abstract LB285: Single cell characterization of the adjacent primed tissues and metastatic microenvironment of adrenocortical carcinoma reveals profound molecular and cellular reprograms that dictate metastatic progression and disease outcome (2023) (0)
- 209 Genetically engineered myeloid cells (GEMys) as a platform to enhance antitumor immunity (2021) (0)
- Bone marrow-derived cells contribute to developing lymph vessels at the tumor invasive front (2008) (0)
- 397 Deep myeloid cell profiling provides new insights into modulators of CAR T cell expansion in patients with solid tumor malignancies (2022) (0)
- Function of circulating myeloid cells in healthy donors and patients with metastatic solid tumors (2021) (0)
- Abstract 4725: Hematopoietic stem cell niche activation and progenitor mobilization mediate cancer-associated immunosuppression and metastasis (2015) (0)
- Immunotherapy for solid tumors: Chimeric antigen receptor (CAR) T-cells and the tumor microenvironment (2020) (0)
This paper list is powered by the following services:
Other Resources About Rosandra N. Kaplan
What Schools Are Affiliated With Rosandra N. Kaplan?
Rosandra N. Kaplan is affiliated with the following schools:
